185 related articles for article (PubMed ID: 36681663)
1. Obesity promotes radioresistance through SERPINE1-mediated aggressiveness and DNA repair of triple-negative breast cancer.
Su YH; Wu YZ; Ann DK; Chen JL; Kuo CY
Cell Death Dis; 2023 Jan; 14(1):53. PubMed ID: 36681663
[TBL] [Abstract][Full Text] [Related]
2. Fisetin induces DNA double-strand break and interferes with the repair of radiation-induced damage to radiosensitize triple negative breast cancer cells.
Khozooei S; Lettau K; Barletta F; Jost T; Rebholz S; Veerappan S; Franz-Wachtel M; Macek B; Iliakis G; Distel LV; Zips D; Toulany M
J Exp Clin Cancer Res; 2022 Aug; 41(1):256. PubMed ID: 35989353
[TBL] [Abstract][Full Text] [Related]
3. A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types.
Dinkelborg PH; Wang M; Gheorghiu L; Gurski JM; Hong TS; Benes CH; Juric D; Jimenez RB; Borgmann K; Willers H
Breast Cancer Res Treat; 2019 Apr; 174(3):605-613. PubMed ID: 30607635
[TBL] [Abstract][Full Text] [Related]
4. Nuclear isoform of RAPH1 interacts with FOXQ1 to promote aggressiveness and radioresistance in breast cancer.
Liu Q; Cao Y; Wei X; Dong H; Cui M; Guan S; Liu B; Wang X; Xing P
Cell Death Dis; 2023 Dec; 14(12):803. PubMed ID: 38062011
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of SERPINE1 reverses resistance of triple‑negative breast cancer to paclitaxel via suppression of VEGFA.
Zhang Q; Lei L; Jing D
Oncol Rep; 2020 Nov; 44(5):1875-1884. PubMed ID: 33000256
[TBL] [Abstract][Full Text] [Related]
6. ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer.
Tu X; Kahila MM; Zhou Q; Yu J; Kalari KR; Wang L; Harmsen WS; Yuan J; Boughey JC; Goetz MP; Sarkaria JN; Lou Z; Mutter RW
Mol Cancer Ther; 2018 Nov; 17(11):2462-2472. PubMed ID: 30166399
[TBL] [Abstract][Full Text] [Related]
7. Obesity-induced MBD2_v2 expression promotes tumor-initiating triple-negative breast cancer stem cells.
Teslow EA; Mitrea C; Bao B; Mohammad RM; Polin LA; Dyson G; Purrington KS; Bollig-Fischer A
Mol Oncol; 2019 Apr; 13(4):894-908. PubMed ID: 30636104
[TBL] [Abstract][Full Text] [Related]
8. Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibody.
Song H; Hedayati M; Hobbs RF; Shao C; Bruchertseifer F; Morgenstern A; Deweese TL; Sgouros G
Mol Cancer Ther; 2013 Oct; 12(10):2043-54. PubMed ID: 23873849
[TBL] [Abstract][Full Text] [Related]
9. THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple-Negative Breast Cancer.
Bai X; Ni J; Beretov J; Wang S; Dong X; Graham P; Li Y
Adv Sci (Weinh); 2021 Dec; 8(24):e2102658. PubMed ID: 34708581
[TBL] [Abstract][Full Text] [Related]
10. TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer.
Ma Y; Zhang H; Chen C; Liu L; Ding T; Wang Y; Ma D; Ling X; Chen X; Li J; Guansheng ; Zhong ; Ru G; Zhang L; Tang J
Oncogene; 2022 Mar; 41(11):1589-1599. PubMed ID: 35091679
[TBL] [Abstract][Full Text] [Related]
11. Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells.
Wen Y; Dai G; Wang L; Fu K; Zuo S
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30842344
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of POU3F2 promotes radioresistance in triple-negative breast cancer via Akt pathway activation.
Zhang H; Zheng J; Fu Y; Ling J; Liu Z; Lin X; Dong X; Sun Y; Tan T; Guo Z; Xie G
Breast Cancer Res Treat; 2023 Apr; 198(3):437-446. PubMed ID: 36797433
[TBL] [Abstract][Full Text] [Related]
13. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.
Yin L; Gao Y; Zhang X; Wang J; Ding D; Zhang Y; Zhang J; Chen H
Oncotarget; 2016 Jul; 7(27):42126-42138. PubMed ID: 27363012
[TBL] [Abstract][Full Text] [Related]
14. Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells.
Michmerhuizen AR; Chandler B; Olsen E; Wilder-Romans K; Moubadder L; Liu M; Pesch AM; Zhang A; Ritter C; Ward ST; Santola A; Nyati S; Rae JM; Hayes D; Feng FY; Spratt D; Wahl D; Eisner J; Pierce LJ; Speers C
Front Endocrinol (Lausanne); 2020; 11():35. PubMed ID: 32117061
[TBL] [Abstract][Full Text] [Related]
15. CPNE1 predicts poor prognosis and promotes tumorigenesis and radioresistance via the AKT singling pathway in triple-negative breast cancer.
Shao Z; Ma X; Zhang Y; Sun Y; Lv W; He K; Xia R; Wang P; Gao X
Mol Carcinog; 2020 May; 59(5):533-544. PubMed ID: 32181526
[TBL] [Abstract][Full Text] [Related]
16. Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer.
Jabbour-Leung NA; Chen X; Bui T; Jiang Y; Yang D; Vijayaraghavan S; McArthur MJ; Hunt KK; Keyomarsi K
Mol Cancer Ther; 2016 Apr; 15(4):593-607. PubMed ID: 26826118
[TBL] [Abstract][Full Text] [Related]
17. miR-1290 modulates the radioresistance of triple-negative breast cancer by targeting NLRP3-mediated pyroptosis.
Li Y; Li X
Clin Transl Oncol; 2022 Sep; 24(9):1764-1775. PubMed ID: 35471684
[TBL] [Abstract][Full Text] [Related]
18. ATM Expression Is Elevated in Established Radiation-Resistant Breast Cancer Cells and Improves DNA Repair Efficiency.
Bian L; Meng Y; Zhang M; Guo Z; Liu F; Zhang W; Ke X; Su Y; Wang M; Yao Y; Wu L; Li D
Int J Biol Sci; 2020; 16(7):1096-1106. PubMed ID: 32174787
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous Targeting of RSK and AKT Efficiently Inhibits YB-1-Mediated Repair of Ionizing Radiation-Induced DNA Double-Strand Breaks in Breast Cancer Cells.
Lettau K; Zips D; Toulany M
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):567-580. PubMed ID: 32931865
[TBL] [Abstract][Full Text] [Related]
20. Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer.
Zhang L; Bochkur Dratver M; Yazal T; Dong K; Nguyen A; Yu G; Dao A; Bochkur Dratver M; Duhachek-Muggy S; Bhat K; Alli C; Pajonk F; Vlashi E
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):195-207. PubMed ID: 30196056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
